Macrophage Activation in HIV-2-Infected Patients Is Less Affected by Antiretroviral Treatment-sCD163 in HIV-1, HIV-2, and HIV-1/2 Dually Infected Patients

被引：8
|
作者：
Honge, Bo L. [1 ,2 ,3 ]
Andersen, Morten N. [4 ,5 ]
Jespersen, Sanne [2 ,3 ]
Medina, Candida [6 ]
Correira, Faustino G. [6 ]
Jakobsen, Martin R. [5 ]
Laursen, Alex [3 ]
Erikstrup, Christian [1 ]
Moller, Holger J. [4 ]
Wejse, Christian [2 ,3 ,7 ]
机构：
[1] Aarhus Univ Hosp, Dept Clin Immunol, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark
[2] Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau
[3] Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark
[4] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark
[5] Aarhus Univ, Dept Biomed, Aarhus, Denmark
[6] Minist Hlth, Natl HIV Programme, Bissau, Guinea Bissau
[7] Aarhus Univ, Sch Publ Hlth, Ctr Global Hlth, GloHAU, Aarhus, Denmark
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2016年 / 72卷 / 03期
基金：
美国国家卫生研究院;
关键词：
HIV; HIV-1; HIV-2; AIDS; CRP; sCD163; Guinea-Bissau; Africa; GUINEA-BISSAU; CD163;
D O I：
10.1097/QAI.0000000000000939
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The course of disease among HIV-2, HIV-1, and HIV-1/2 dually infected patients is different. We investigated the macrophage activation marker soluble CD163 (sCD163) dynamics in 212 HIV-1, HIV-2, and HIV-1/2 dually infected patients. There were no differences in sCD163 levels at baseline or during follow-up without antiretroviral therapy (ART). At follow-up on ART, median sCD163 levels were decreased for HIV-1-infected patients (P < 0.001), but not among HIV-2 (P = 0.093) or HIV-1/2 dually infected patients (P = 0.145). The larger decrease in sCD163 levels among HIV-1-infected patients during ART may indicate an HIV type-dependent differential effect of ART on macrophage activation during HIV infection.
引用
收藏
页码：254 / 258
页数：5
相关论文
共 50 条
  • [11] HIV-1 Superinfection in an HIV-2-Infected Woman with Subsequent Control of HIV-1 Plasma Viremia
    Guenthard, Huldrych F.
    Huber, Milo
    Kuster, Herbert
    Shah, Cyril
    Schuepbach, Joerg
    Trkola, Alexandra
    Boeni, Juerg
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 48 (11) : E117 - E120
  • [12] Plasma and tissue HIV-1 and HIV-2 viral load in HIV-2 and dual HIV-1/HIV-2 infected individuals: Implications for starting HAART
    Schutten, M
    van der Ende, ME
    Tenner-Racz, K
    Racz, P
    Niesters, HGM
    Osterhaus, ADME
    [J]. AIDS, 2000, 14 : S3 - S3
  • [13] Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain
    Requena, Silvia
    Caballero, Estrella
    Belen Lozano, Ana
    Jose Rios-Villegas, Maria
    Benito, Rafael
    Rojo, Silvia
    Cabezas, Teresa
    Dolores Macia, Maria
    del Carmen Nieto, Maria
    Soriano, Vicente
    de Mendoza, Carmen
    Rodriguez, C.
    Vera, M.
    del Romero, J.
    Ocete, M. D.
    Caballero, E.
    Aguilera, A.
    Amengual, M. J.
    Cervantes, M.
    Benito, R.
    Algarate, S.
    Ortiz de Lejarazu, R.
    Rojo, S.
    Eiros, J. M.
    Ramos, C.
    Garcia-Costa, J.
    Calderon, E.
    Rios-Villegas, M. J.
    Trigo, M.
    Diz, J.
    Garcia-Campello, M.
    Rodriguez-Iglesias, M.
    Hernandez-Betancor, A.
    Ramos, J. M.
    Gimeno, A.
    Sanchez, V
    Gomez-Hernando, C.
    Echeverria, M. J.
    Cilla, G.
    Perez-Trallero, E.
    Fernandez-Pereira, L.
    Niubo, J.
    Margall, N.
    Hernandez, M.
    Lopez-Lirola, A. M.
    Gomez-Sirvent, J. L.
    Force, L.
    Sauca, M.
    Perez, S.
    Morano, L.
    [J]. AIDS, 2019, 33 (14) : 2167 - 2172
  • [14] Management of HIV-2 resistance to antiretroviral therapy in a HIV-1/HIV-2/HBV co-infected patient
    Cardoso, Margarida
    Vasconcelos, Joana
    Baptista, Teresa
    Diogo, Isabel
    Goncalves, Fatima
    Mansinho, Kamal
    Gomes, Perpetua
    [J]. AIDS RESEARCH AND THERAPY, 2021, 18 (01)
  • [15] Management of HIV-2 resistance to antiretroviral therapy in a HIV-1/HIV-2/HBV co-infected patient
    Margarida Cardoso
    Joana Vasconcelos
    Teresa Baptista
    Isabel Diogo
    Fátima Gonçalves
    Kamal Mansinho
    Perpétua Gomes
    [J]. AIDS Research and Therapy, 18
  • [16] Mortality and immunovirological outcomes on antiretroviral therapy in HIV-1 and HIV-2-infected individuals in the Gambia
    Peterson, Ingrid
    Togun, Oluwatoyin
    de Silva, Thushan
    Oko, Francis
    Rowland-Jones, Sarah
    Jaye, Assan
    Peterson, Kevin
    [J]. AIDS, 2011, 25 (17) : 2167 - 2175
  • [17] Virological Response to Highly Active Antiretroviral Therapy in Patients Infected with Human Immunodeficiency Virus Type 2 (HIV-2) and in Patients Dually Infected with HIV-1 and HIV-2 in The Gambia and Emergence of Drug-Resistant Variants
    Jallow, Sabelle
    Alabi, Abraham
    Sarge-Njie, Ramu
    Peterson, Kevin
    Whittle, Hilton
    Corrah, Tumani
    Jaye, Assan
    Cotten, Matthew
    Vanham, Guido
    McConkey, Samuel J.
    Rowland-Jones, Sarah
    Janssens, Wouter
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (07) : 2200 - 2208
  • [18] Survival of HIV-1 and HIV-2 perinatally infected children in The Gambia
    van der Loeff, MFS
    Hansmann, A
    Awasana, AA
    Ota, MO
    O'Donovan, D
    Sarge-Njie, R
    Ariyoshi, K
    Milligan, P
    Whittle, H
    [J]. AIDS, 2003, 17 (16) : 2389 - 2394
  • [19] IS HIV-2 LESS PATHOGENIC THAN HIV-1
    MARLINK, R
    KANKI, P
    THIOR, I
    SIBY, T
    MBOUP, S
    ESSEX, M
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (01) : 75 - 76
  • [20] Incidence of tuberculosis and survival after its diagnosis in patients infected with HIV-1 and HIV-2
    van der Sande, MAB
    van der Loeff, MFS
    Bennett, RC
    Dowling, M
    Aveika, AA
    Togun, TO
    Sabally, S
    Jeffries, D
    Adegbola, RA
    Sarge-Njie, R
    Jaye, A
    Corrah, T
    McConkey, S
    Whittle, HC
    [J]. AIDS, 2004, 18 (14) : 1933 - 1941
12345